DICERNA PHARMACEUTICALS INC's ticker is DRNA and the CUSIP is 253031108. A total of 1 filers reported holding DICERNA PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $278,000 | -45.9% | 13,778 | 0.0% | 0.00% | -50.0% |
| Q2 2021 | $514,000 | +46.0% | 13,778 | 0.0% | 0.00% | 0.0% |
| Q1 2021 | $352,000 | +15.8% | 13,778 | 0.0% | 0.00% | +100.0% |
| Q4 2020 | $304,000 | +22.6% | 13,778 | 0.0% | 0.00% | 0.0% |
| Q3 2020 | $248,000 | -29.1% | 13,778 | 0.0% | 0.00% | -50.0% |
| Q2 2020 | $350,000 | – | 13,778 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aquilo Capital Management, LLC | 2,456,595 | $49,525,000 | 9.00% |
| COMMODORE CAPITAL LP | 1,292,251 | $26,052,000 | 6.87% |
| Bain Capital Life Sciences Investors, LLC | 3,080,237 | $62,098,000 | 3.85% |
| GREAT POINT PARTNERS LLC | 799,999 | $16,128,000 | 3.76% |
| DAFNA Capital Management LLC | 587,456 | $11,843,000 | 3.14% |
| Eagle Health Investments LP | 406,525 | $8,196,000 | 2.60% |
| RTW INVESTMENTS, LP | 7,582,396 | $152,861,000 | 2.30% |
| Parkman Healthcare Partners LLC | 209,686 | $4,227,000 | 1.07% |
| Palo Alto Investors LP | 855,713 | $17,251,000 | 1.04% |
| Lombard Odier Asset Management (Switzerland) SA | 701,305 | $14,138,000 | 0.88% |